Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' DEFICIT (Tables)

v3.3.1.900
STOCKHOLDERS' DEFICIT (Tables)
 12 Months Ended
Sep. 30, 2015
Stockholders' Equity Note [Abstract]  
Schedule of stock-based compensation expense

Stock-based compensation expenses are generally recognized over the employees’ or service provider’s requisite service period, generally the vesting period of the award. Stock-based compensation expense included in the accompanying statements of operations for the year ended September 30, 2015 and 2014 is as follows:   

 

    September 30  
    2015     2014  
Cost of Neurometric Services revenues   $ —     $ 5,100  
Research     41,600       65,500  
Product Development     52,300       249,700  
Sales and marketing     81,600       87,700  
General and administrative     66,200       600,700  
Total   $ 241,700     $ 1,008,700  
Schedule of stock option activity

A summary of stock option activity is as follows:

 

    Number of 
Shares 		    Weighted
Average 
Exercise
Price 		 
Outstanding at September 30, 2013     9,749,594     $ 1.00  
Granted     2,725,000       0.25  
Exercised     -          
Forfeited     (57,095 )     12.67  
Outstanding at September 30, 2014     12,417,499     $ 0.84  
Granted     2,000,000       0.08  
Exercised     -       -  
Forfeited     (187,488 )     0.11  
Outstanding at September 30, 2015     14,230,011     $ 0.75  
Schedule of the status of options outstanding

Following is a summary of the status of options outstanding at September 30, 2015:

 

Exercise
Price ($) 		    Number
of Shares 		    Expiration
Date 		  Weighted Average
Exercise Price ($) 		 
                         
$ 0.055       1,750,000     08/2025   $ 0.055  
  0.04718       8,795,308     12/2022 – 01/2023     0.04718  
  0.25       2,715,109     03/2023 – 01/2025     0.25  
  0.26       425,000     07/2024     0.26  
  3.00       42,670     03/2022     3.00  
  3.60       28,648     08/2016     3.60  
  3.96       32,928     08/2016     3.96  
  9.00       4,525     11/2016     9.00  
  12.00       28,535     03/2019 – 07/2020     12.00  
  14.10       10,000     03/2021     14.10  
  15.30       1,373     09/2018     15.30  
  16.50       262,441     03/2020     16.50  
  17.70       953     08/2016     17.70  
  24.00       4,667     12/2017     24.00  
  26.70       32,297     09/2017     26.70  
  28.80       11,767     04/2018     28.80  
$ 32.70       83,790     08/2017   $ 32.70  
  Total       14,230,011     Average   $ 0.75  
Schedule of share-based compensation warrants

The warrant activity for the period starting October 1, 2013, through September 30, 2015, is described as follows:

 

    Number of 
Shares 		    Weighted
Average 
Exercise Price 		 
Outstanding at October 1, 2013     1,497,556     $ 3.03  
Granted     152,200       0.27  
Exercised     (608,309 )     0.04718  
Expired     (226,703 )     9.14  
Outstanding at September 30, 2014     814,744     $ 3.07  
Granted     200,000       0.25  
Exercised     —       —  
Expired     (233,220 )     9.14  
Outstanding at September 30, 2015     781,524     $ 0.53  
Schedule of the status of warrants outstanding

Following is a summary of the status of warrants outstanding at September 30, 2015:

 

Exercise
Price 		    Number
of Shares 		    Expiration
Date 		  Weighted Average
Exercise Price 		 
                         
$ 0.04718       38,152     03/2018   $ 0.04718  
  0.25       332,200     04/2016 – 07/2017     0.25  
  0.275       324,000     06/2018 – 03/2019     0.275  
  1.00       67,170     10/2015 – 01/2017     1.00  
  7.50       3,334     05/2016     7.50  
$ 9.00       16,668     07/2017     9.00  
  Total       781,524         $ 0.53